Insperity price target lowered to $62 at Roth Capital, named top pick for 2026

Roth Capital analyst Jeff Martin lowered the firm’s price target on Insperity (NSP) to $62 from $71 and keeps a Buy rating on the shares. The firm names the stock a top pick for 2026. Insperity’s profits should significantly improve in 2026 as elevated healthcare benefit costs ease. Further, the company should see a gradual ramp of middle-market clients on its joint solution with Workday (WDAY), adds Roth. The firm believes this will position Insperity for growth acceleration and margin gains in 2027 that should drive the stock’s multiple back to its historical valuation of 12-15 times adjusted EBITDA.